NCT06221527

Brief Summary

HA is favorable for osteogenesis, enhancing bone growth, acting a vector for osteoinductive compounds and promoting even distribution and increased density of newly formed bone, thereby altering the scaffold morphology and improving mineralization. In this study 22 volunteers will be included in this study, the volunteers will be randomly distributed into two groups each containing 11 volunteers, one group will be treated by hyaluronic acid before fixation and the other group will be treated by fixation only without placement of hyaluronic acid, to compensate for drop out 13 volunteers per group

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

January 15, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 24, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

January 24, 2024

Status Verified

January 1, 2024

Enrollment Period

8 months

First QC Date

January 15, 2024

Last Update Submit

January 23, 2024

Conditions

Keywords

parasymphyseal fracturehyaluronic acid

Outcome Measures

Primary Outcomes (1)

  • Patient satisfaction(score)

    Patient satisfaction survey through score

    at one week and three months intervals

Secondary Outcomes (1)

  • Fracture gap distance(mm)

    immediate postoperative and four months intervals

Other Outcomes (3)

  • BV\TV (Bone Volume Fraction ) (%)

    immediate postoperative and four months intervals

  • Pain(VAS)

    at one week and three months intervals

  • Wound dehiscence(Binary)

    at one week and three months intervals

Study Arms (2)

conventional group

ACTIVE COMPARATOR

fixation of parasymphyseal fracture using two four-hole titanium miniplates that will be placed on inferior border and another one on superior border.

Procedure: conventional group

study group

ACTIVE COMPARATOR

placement of hyaluronic acid will be carried over gel foam and placed between fractured segments before plate fixation. fixation of parasymphyseal fracture using two four-hole titanium miniplates that will be placed on inferior border and another one on superior border.

Procedure: conventional group

Interventions

fixation of parasymphyseal fracture using two four-hole titanium miniplates that will be placed on inferior border and another one on superior border

Also known as: study group,- Placement of hyaluronic acid paste will be carried over gel foam and placed between fractured segments of parasymphysial before plate fixation
conventional groupstudy group

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with unilateral Para symphyseal fracture
  • Systemically healthy patients (American Society of Anesthesiologists -ASA I and II)
  • Age of the patient above 16 years to 60 years old
  • Patient of both sexes
  • Patients willing for the surgical procedure and follow up with an informed consent.

You may not qualify if:

  • Bad oral hygiene
  • smokers (\>10cigarettes/day)
  • Existence of a bone metabolic disease; currently taking drugs that might influence bone metabolism
  • Radiotherapy or chemotherapy form malignancy
  • Patients who refused to sign consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Double(Participant, Outcome Assessor)
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: comparison between healing properties using hyaluronic acid topical application and not using it in parasymphyseal fracture
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

January 15, 2024

First Posted

January 24, 2024

Study Start

January 1, 2024

Primary Completion

September 1, 2024

Study Completion

January 1, 2025

Last Updated

January 24, 2024

Record last verified: 2024-01